Switching would require a new titration period (starting at 2mg and escalating over 812 weeks to target dose), may temporarily restart GI side effects, and would need new insurance prior authorization
Food and Drug Administration in mid-2022, Mounjaro generated $5.2 billion in sales worldwide in 2023, and that jumped to $11.5 billion in 2024
Accelerated bone loss layered on top of postmenopausal bone decline
Potential Complications of Dermal Fillers and How to Minimize Them Dermal fillers have become a popular non-surgical solution for restoring volume, smoothing wrinkles, and enhancing facial contours
Liu, T., Liu, Y., Zhao, X., Zhang, L., Wang, W., Bai, D.,
Our TRPC3/6/7 inhibitor, Xolatryp, recently completed a successful Phase I study demonstrating safety, tolerability, and linear pharmacokinetics